B
미래아이앤지
007120KOSPI59.3 / 100
Reference Date: 2026-09-08
Financial Score21.0 / 40
News Sentiment21.3 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Mirae I&G primarily operates in financial solutions and B&E business, offering SWIFT solution management (eNisis) and foreign exchange trading solutions (Summit) to major banks. Revenue in 2025 reached 14.13 billion KRW, a 21% increase from the previous year, driven by continuous upgrades of its proprietary programs and expansion into building leasing operations.
Number of Employees
42people
Average Salary
51.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
0.66Industry Average 1.205.5Point
Lower than industry avg (good)
ROE
-5.22Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
30.59Industry Average 100.006.5Point
Half of industry avg (excellent)
Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3
Avg ▲5.3% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲25.5% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -11.5% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85
- Positive케이바이오랩스, 상반기 흑자 전환 성공…전년比 매출 28%↑
케이바이오랩스의 상반기 흑자 전환과 매출 증가로 인해 긍정적인 시장 반응이 예상됩니다.
Detailed Momentum
52-week position3.0Point
52w lower range (23%)
Current 1,171Won52-week high 2,40552-week low 798
1-month return3.0Point
1m 0% (flat)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral반기보고서 (2026.06)2026-08-14